GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Pain Therapeutics (PTIE) CEO and Chairman of Board, 10% Owner Remi Barbier sells 50,000 Shares

June 03, 2010 | About:
insider

insider

57 followers
CEO and Chairman of Board, 10% Owner of Pain Therapeutics (PTIE) Remi Barbier sells 50,000 shares of PTIE on 06/03/2010 at an average price of $5.53 a share.

Pain Therapeutics has a market cap of $236.5 million; its shares were traded at around $5.59 with and P/S ratio of 11.5.

PTIE is in the portfolios of Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.

This is the annual revenues and earnings per share of PTIE over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PTIE.


CEO Recent Trades:



  • Sell:: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 6,576 shares of PTIE stock on 05/06/2010 at the average price of 5.61, the price of the stock has decreased by 0.36% since.
  • Sell:: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 43,424 shares of PTIE stock on 05/05/2010 at the average price of 5.91, the price of the stock has decreased by 5.41% since.
  • Sell:: CEO and Chairman of Board, 10% Owner Remi Barbier sold 5,800 shares of PTIE stock on 04/07/2010 at the average price of 6.23, the price of the stock has decreased by 10.27% since.
  • Sell:: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 32,200 shares of PTIE stock on 04/06/2010 at the average price of 6.25, the price of the stock has decreased by 10.56% since.
  • Sell:: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 12,000 shares of PTIE stock on 04/01/2010 at the average price of 6.16, the price of the stock has decreased by 9.25% since.



This is the insider trade history vs. stock price of PTIE. For the complete insider trading history of PTIE, click here.




Directors and Officers Recent Trades:



  • Sell:: Chief Scientific Officer Grant Schoenhard sold 10,979 shares of PTIE stock on 05/27/2010 at the average price of 5.74, the price of the stock has decreased by 2.61% since.
  • Sell:: Chief Scientific Officer Grant Schoenhard sold 2,486 shares of PTIE stock on 05/19/2010 at the average price of 5.77, the price of the stock has decreased by 3.12% since.
  • Sell:: Chief Scientific Officer Grant Schoenhard sold 13,035 shares of PTIE stock on 05/18/2010 at the average price of 5.77, the price of the stock has decreased by 3.12% since.
  • Sell:: COO Nadav Friedmann sold 15,000 shares of PTIE stock on 05/04/2010 at the average price of 5.95, the price of the stock has decreased by 6.05% since.
  • Sell:: Chief Scientific Officer Grant Schoenhard sold 26,500 shares of PTIE stock on 04/16/2010 at the average price of 6.29, the price of the stock has decreased by 11.13% since.


  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.5/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK